Pathomechanisms Inducing and Perpetuating an Autoimmune Response in Psoriasis vulgaris
Pathomechanisms Inducing and Perpetuating an Autoimmune Response in Psoriasis vulgaris
批准号:
317045689
负责人:
Professor Dr. Jörg Christoph Prinz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2021-12-31
中文摘要
银屑病是一种复杂的T细胞介导的自身免疫性疾病,涉及遗传易感性和环境危险因素。HLAI类等位基因HLAC*06:02是银屑病的主要易感基因。银屑病的风险是由人类白细胞抗原-C*06:02和内质网氨基肽酶I(ERAP1)的某些变异体之间的上位性调节的,该变异体将前体多肽修剪到合适的长度,以便与人类白细胞抗原I类分子的多肽结合沟结合。由于人类白细胞抗原I类分子将抗原从细胞内蛋白递送到CD8+T细胞,因此人类白细胞抗原I类限制性免疫反应必须针对特定的靶细胞。银屑病皮损发生于表皮浸润和CD8+T细胞活化。利用一例人类白细胞抗原-C*06:02阳性银屑病患者皮损表面CD8+T细胞克隆的致病T细胞受体(TCR),我们证明了人类白细胞抗原-C*06:02介导了一种针对黑素细胞的自身免疫反应,并从ADAMTS样蛋白5中鉴定出一种多肽自身抗原(ADAMTSL5)为黑素细胞自身抗原。这些数据为银屑病炎症的自身免疫性建立了直接的实验证据,并为正在进行的和计划中的研究项目提供了基础。因此,致病的银屑病V Alpha 3S1/V Beta 13S1-TCR为阐明银屑病的免疫发病机制提供了独特的机会。到目前为止,还没有在其他人类自身免疫性疾病中成功实施类似的方法。在正在进行的项目中,我们可以证明促炎信号与易感的HLA类等位基因在促进T细胞介导的银屑病自身免疫反应中协同作用,我们提供的数据表明,银屑病的全身炎症至少部分是由皮肤炎症引起的。我们鉴定了自身抗原性银屑病ADAMTLS5肽的特殊结构特征。我们发现ERAP1的保护性和风险性变异体通过不同的抗原肽的供应来影响针对ADAMTSL5的HLA-C*06:02限制性自身免疫反应。我们通过Vα3S1/Vβ13S1-TCR的交叉反应,从病原体、微生物群和食物中鉴定了几种可能诱导ADAMTSL5特异性自身免疫反应的环境抗原。在更新方案中,我们计划完成对ERAP1在针对ADAMTSL5和黑素细胞的HLAC*06:02限制性自身免疫反应中的特定作用的分析;我们打算分析环境触发抗原与诱导针对ADAMTSL5的交叉反应性自身免疫反应的潜在相关性;我们计划鉴定B细胞自身抗原(S),它可能激活ADAMTSL5特异性的Vα3S1/Vβ13S1-TCR并维持持续的自身反应性银屑病T细胞的供应。总体而言,从这些方法获得的见解可能会完整地了解银屑病的自身免疫发病机制,并为T细胞介导的自身免疫提供一个一般概念。
英文摘要
Psoriasis is a complex T-cell mediated autoimmune disease involving genetic predisposition and environmental risk factors. The HLA-class I-allele HLA-C*06:02 is the main psoriasis risk gene. Psoriasis risk is modulated by epistasis between HLA-C*06:02 and certain variants of endoplasmic reticulum aminopeptidase I (ERAP1) which trims precursor peptides to the appropriate length for binding to the peptide-binding groove of HLA class I molecules. Because HLA-class I-molecules present peptide antigens from intracellular proteins to CD8+ T cells, an HLA-class I restricted immune response must be directed against a particular target cell. Psoriasis lesions develop upon epidermal infiltration and activation of CD8+ T cells. Using a pathogenic T-cell receptor (TCR) from a lesional epidermal CD8+ T cell clone of an HLA-C*06:02-positive psoriasis patient we had shown that HLA-C*06:02 mediates an autoimmune response against melanocytes, and we had identified a peptide autoantigen from ADAMTS-like protein 5 (ADAMTSL5) as melanocytic autoantigen. These data established direct experimental evidence for the autoimmune nature of psoriatic inflammation and they provide the basis for the ongoing and the projected research project. For this, the pathogenic psoriatic V Alpha 3S1 / V Beta 13S1-TCR represents a unique opportunity for elucidating the immunopathogenesis of psoriasis. In no other human autoimmune disease a similar approach has been successfully conducted yet. In the ongoing project we could demonstrate that proinflammatory signals cooperate with predisposing HLA-class alleles in promoting the T-cell mediated psoriatic autoimmune response, and we provided data showing that systemic inflammation in psoriasis at least partially results from skin inflammation. We characterized particular structural features of the autoantigenic psoriatic ADAMTLS5 peptide. We showed that protective and risk variants of ERAP1 affect the HLA-C*06:02-restricted autoimmune response against ADAMTSL5 through differential supply of antigenic peptides from NH2-terminal elongated peptide precursors for HLA binding. We identified several environmental antigens from pathogens, microbiota and food that might induce an ADAMTSL5-specific autoimmune response through cross-reactivity of the Vα3S1/Vβ13S1-TCR.In the renewal proposal we plan to finalize the analysis of the specific role of ERAP1 in the HLA-C*06:02-restricted autoimmune response against ADAMTSL5 and melanocytes; we intend to analyze the potential relevance of environmental trigger antigens for inducing a cross-reactive autoimmune response against ADAMTSL5; and we plan to identify B-cell autoantigen(s) which may activate the ADAMTSL5-specific Vα3S1/Vβ13S1-TCR and maintain a continuous supply of autoreactive melanocyte-specific psoriatic T cells. Overall, the insights obtained from these approaches may complete understanding of psoriatic autoimmune pathogenesis and provide a general concept for T-cell mediated autoimmunity.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Genetic analysis of MPO variants in four psoriasis subtypes in patients from Germany.
德国患者四种银屑病亚型 MPO 变异的遗传分析
DOI:
10.1016/j.jid.2021.01.017
发表时间:
2021
期刊:
The Journal of investigative dermatology
影响因子:
--
作者:
[Haskamp, J. S. Horowitz, V. Oji, S. Philipp, M. Sticherling, K. Schakel, S. Schuhmann, J. C. Prinz, H. Burkhardt, F. Behrens, B. Bohm, M. Kohm, J. Rech, D. Simon, G. Schett, K. Morrison, S. Gerdes, G. Assmann, A. Nimeh, V. Schuster, A. Jacobi, A. Weye]
通讯作者:
A. Weye
DOI:
10.3389/fimmu.2019.01336
发表时间:
2019-06-18
期刊:
FRONTIERS IN IMMUNOLOGY
影响因子:
7.3
作者:
[Arakawa, Akiko, Vollmer, Sigrid, Prinz, Joerg C.]
通讯作者:
Prinz, Joerg C.
DOI:
10.1016/j.jid.2021.05.009
发表时间:
2021-07
期刊:
The Journal of investigative dermatology
影响因子:
--
作者:
[J. Prinz]
通讯作者:
J. Prinz
DOI:
10.1016/j.ajhg.2020.07.001
发表时间:
2020-09-03
期刊:
AMERICAN JOURNAL OF HUMAN GENETICS
影响因子:
9.8
作者:
[Haskamp, Stefan, Bruns, Heiko, Hueffmeier, Ulrike]
通讯作者:
Hueffmeier, Ulrike
Identification of the psoriatic autoantigens by single cell T-cell receptor (TCR) analysis and recombinant TCR hybridomas
-
批准号:207512308
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professor Dr. Jörg Christoph Prinz
-
依托单位:
Etablierung eines transgenen Mausmodells für Psoriasis vulgaris
-
批准号:5233024
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Jörg Christoph Prinz
-
依托单位:
国内基金
海外基金
基础于人参提取的促醒(Wakefulness-inducing)药物研究
-
批准号:39422002
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:1994
-
负责人:刘世熠
-
依托单位: